Hospital
RCCH Trios Health LLC
RCCH Trios Health LLC was paid $44.44M by Medicaid between Aug 2018 and Dec 2024, across 410 billing codes. Its largest line is G0463, Hospital outpatient clinic visit for assessment and management of a patient — 43% of everything it billed.
33Billing provider infoRCCH TRIOS HEALTH LLC
KENNEWICK, WA 99338
KENNEWICK, WA 99338
33aNPI1578058137assigned 06/26/2018
33bProvider typeGeneral Acute Care Hospital
28Total paid$44.44M
24GClaims1,173,881
24DCodes billed410
24AFirst – last monthAug 2018 – Dec 2024
Compared with peers
Next to other General Acute Care Hospital providers in Washington
Rank by total paid#14 of 49
Median peer was paid$20.06M
This provider vs. median2.2×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Auditor's notes
Automated statistical signals. Not evidence of fraud — how these are computed.
Entity ProliferationAuthorized official LAWRENCE, CHARLOTTE controls 20+ related entities in our dataset. Read more
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 59,973 | $2.39M | |
| 2019 | 188,641 | $5.96M | |
| 2020 | 181,893 | $6.09M | |
| 2021 | 201,511 | $7.19M | |
| 2022 | 196,221 | $8.02M | |
| 2023 | 201,854 | $8.04M | |
| 2024incomplete | 143,788 | $6.74M |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| G0463 | Hospital outpatient clinic visit for assessment and management of a patient | 43% | 203,024 | 159,663 | $19.02M |
| 99283 | Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity | 7.2% | 27,954 | 26,362 | $3.22M |
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 5.5% | 22,300 | 19,947 | $2.46M |
| 96361 | Intravenous infusion, hydration; each additional hour | 5.1% | 8,844 | 6,114 | $2.25M |
| 99284 | Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity | 4.3% | 23,948 | 21,816 | $1.93M |
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 2.4% | 10,504 | 9,351 | $1.09M |
| 59025 | Fetal non-stress test | 2.0% | 7,284 | 4,254 | $910K |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | 1.9% | 6,836 | 6,580 | $856K |
| 74177 | Computed tomography, abdomen and pelvis; with contrast material | 1.6% | 4,719 | 4,465 | $713K |
| 43239 | Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple | 1.6% | 3,052 | 2,752 | $695K |
| 45380 | Colonoscopy, flexible; with biopsy, single or multiple | 1.5% | 2,208 | 2,000 | $679K |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | 1.4% | 44,630 | 40,439 | $620K |
398 more codes
| 99285 | Emergency room visit (most serious) | 1.4% | 8,542 | $613K |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | 1.2% | 7,043 | $555K |
| 96360 | Intravenous infusion, hydration; initial, 31 minutes to 1 hour | 1.1% | 4,279 | $501K |
| 70450 | Computed tomography, head or brain; without contrast material | 1.1% | 3,972 | $481K |
| 93306 | Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete | 1.0% | 2,206 | $449K |
| 96366 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour | <1% | 1,873 | $353K |
| 92507 | Treatment of speech, language, voice, communication, and/or auditory processing disorder | <1% | 8,113 | $337K |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | <1% | 4,575 | $292K |
| 45385 | Colonoscopy, flexible; with removal of tumor(s), polyp(s), or other lesion(s) | <1% | 1,264 | $288K |
| 74176 | Computed tomography, abdomen and pelvis; without contrast material | <1% | 1,712 | $253K |
| 97110 | Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion | <1% | 9,640 | $235K |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | <1% | 2,176 | $224K |
| 90472 | Immunization administration, each additional vaccine (list separately) | <1% | 25,261 | $208K |
| 76705 | Ultrasound, abdominal, real time with image documentation; limited | <1% | 2,806 | $208K |
| 76856 | Ultrasound, pelvic (nonobstetric), real time with image documentation; complete | <1% | 2,756 | $205K |
| 76815 | Ultrasound, pregnant uterus, real time with image documentation, limited | <1% | 3,863 | $193K |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | <1% | 2,851 | $183K |
| 80053 | Comprehensive metabolic panel | <1% | 41,692 | $174K |
| 76805 | Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation | <1% | 2,765 | $171K |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | <1% | 5,713 | $158K |
| 76801 | <1% | 2,980 | $153K | |
| 76700 | Ultrasound, abdominal, real time with image documentation; complete | <1% | 1,615 | $151K |
| 97530 | Therapeutic activities, direct patient contact, each 15 minutes | <1% | 5,222 | $148K |
| 17110 | <1% | 596 | $131K | |
| 97140 | Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) | <1% | 6,182 | $129K |
| 76830 | Ultrasound, transvaginal | <1% | 2,379 | $127K |
| 99203 | Doctor's office visit, new patient (routine) | <1% | 1,113 | $109K |
| 96413 | Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance | <1% | 1,933 | $106K |
| 76819 | Fetal biophysical profile; without non-stress testing | <1% | 2,650 | $90K |
| 45378 | Colonoscopy, flexible; diagnostic, including collection of specimen(s) | <1% | 273 | $88K |
| 97161 | <1% | 1,693 | $83K | |
| 99204 | Doctor's office visit, new patient (more involved) | <1% | 788 | $77K |
| 92523 | <1% | 604 | $76K | |
| 76817 | Ultrasound, pregnant uterus, real time with image documentation, transvaginal | <1% | 1,857 | $67K |
| 76642 | <1% | 869 | $67K | |
| 71046 | Radiologic examination, chest; 2 views | <1% | 5,016 | $65K |
| 95810 | Polysomnography; sleep staging with 4 or more additional parameters | <1% | 156 | $65K |
| 11042 | Debridement, subcutaneous tissue (includes epidermis, dermis, and subcutaneous tissue); first 20 sq cm | <1% | 445 | $63K |
| G0378 | Hospital observation service, per hour | <1% | 2,520 | $63K |
| 76770 | <1% | 734 | $61K | |
| 71275 | Computed tomographic angiography, chest, with contrast material | <1% | 449 | $59K |
| 77067 | Screening mammography, bilateral, including computer-aided detection | <1% | 2,320 | $56K |
| 90686 | <1% | 12,477 | $53K | |
| C9803 | Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source | <1% | 4,821 | $53K |
| 76811 | Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation, detailed | <1% | 914 | $52K |
| 90715 | <1% | 5,417 | $51K | |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | <1% | 44,556 | $46K |
| 76536 | <1% | 572 | $46K | |
| 77063 | Screening digital breast tomosynthesis, bilateral | <1% | 2,318 | $44K |
| 36415 | Collection of venous blood by venipuncture | <1% | 43,077 | $44K |
| 73630 | <1% | 2,455 | $42K | |
| 90651 | <1% | 3,977 | $40K | |
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | <1% | 410 | $40K |
| 99215 | Doctor's office visit, returning patient (complex) | <1% | 386 | $39K |
| 97162 | <1% | 1,038 | $39K | |
| 84443 | Thyroid stimulating hormone (TSH) | <1% | 7,788 | $38K |
| 93971 | <1% | 542 | $38K | |
| 90670 | <1% | 10,193 | $35K | |
| 69209 | <1% | 936 | $31K | |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | <1% | 15,605 | $29K |
| 97803 | <1% | 1,136 | $27K | |
| 12001 | <1% | 142 | $26K | |
| 71260 | Computed tomography, thorax, diagnostic; with contrast material | <1% | 1,007 | $26K |
| 96367 | <1% | 1,127 | $26K | |
| 72110 | <1% | 983 | $24K | |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 10,263 | $24K |
| 84484 | <1% | 7,967 | $24K | |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | <1% | 3,146 | $22K |
| 72148 | Magnetic resonance imaging, lumbar spine; without contrast material | <1% | 184 | $22K |
| 73610 | <1% | 1,705 | $21K | |
| 11043 | <1% | 147 | $20K | |
| 70553 | Magnetic resonance imaging, brain; without contrast material, followed by contrast material and further sequences | <1% | 95 | $20K |
| 73562 | <1% | 1,639 | $20K | |
| 73030 | <1% | 1,572 | $19K | |
| G0108 | Diabetes outpatient self-management training services, individual, per 30 minutes | <1% | 692 | $19K |
| 29125 | <1% | 99 | $19K | |
| 87040 | <1% | 3,934 | $19K | |
| 90648 | <1% | 4,769 | $18K | |
| 87641 | <1% | 1,942 | $18K | |
| 74018 | <1% | 1,714 | $17K | |
| 99202 | Office or other outpatient visit for the evaluation and management of a new patient, straightforward | <1% | 168 | $16K |
| 87502 | Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets | <1% | 1,669 | $16K |
| 80061 | Lipid panel | <1% | 4,505 | $16K |
| 80048 | Basic metabolic panel (calcium, ionized) | <1% | 3,209 | $15K |
| J2469 | Injection, palonosetron hcl, 25 mcg | <1% | 264 | $15K |
| 76816 | Ultrasound, pregnant uterus, real time with image documentation, follow-up | <1% | 228 | $15K |
| 97802 | <1% | 284 | $14K | |
| 58300 | <1% | 141 | $14K | |
| 94729 | <1% | 526 | $13K | |
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | <1% | 1,764 | $13K |
| 83880 | <1% | 3,705 | $13K | |
| 96415 | <1% | 91 | $12K | |
| 94060 | <1% | 637 | $12K | |
| 84145 | <1% | 1,557 | $12K | |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | <1% | 1,149 | $11K |
| 11056 | <1% | 136 | $10K | |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 7,091 | $10K |
| J1453 | Injection, fosaprepitant, 1 mg | <1% | 175 | $10K |
| 36591 | <1% | 1,995 | $10K | |
| 10060 | <1% | 45 | $10K | |
| 85379 | <1% | 1,928 | $9K | |
| 82728 | <1% | 1,578 | $9K | |
| 71045 | Radiologic examination, chest; single view | <1% | 10,326 | $9K |
| 11750 | <1% | 27 | $9K | |
| 87420 | <1% | 2,777 | $9K | |
| 83735 | <1% | 12,180 | $8K | |
| 85027 | <1% | 3,922 | $8K | |
| 72125 | Computed tomography, cervical spine; without contrast material | <1% | 641 | $8K |
| 97166 | <1% | 153 | $8K | |
| 82553 | <1% | 1,222 | $8K | |
| 83605 | <1% | 2,464 | $8K | |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | <1% | 13,892 | $8K |
| 94726 | <1% | 498 | $8K | |
| 99291 | Critical care, evaluation and management of the critically ill patient, first 30-74 minutes | <1% | 239 | $8K |
| 90460 | Immunization administration through 18 years of age via any route, first or only component | <1% | 1,258 | $7K |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | <1% | 1,165 | $7K |
| 77072 | <1% | 145 | $7K | |
| 72040 | <1% | 339 | $7K | |
| 82247 | <1% | 1,524 | $7K | |
| 97165 | <1% | 107 | $6K | |
| 73110 | <1% | 499 | $6K | |
| 90734 | <1% | 1,731 | $6K | |
| 72100 | <1% | 566 | $6K | |
| 87631 | <1% | 323 | $6K | |
| 92526 | <1% | 125 | $6K | |
| 84436 | <1% | 1,410 | $5K | |
| G0480 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed | <1% | 1,206 | $5K |
| 82570 | <1% | 1,626 | $5K | |
| 73130 | <1% | 690 | $5K | |
| 12011 | <1% | 26 | $5K | |
| 83550 | <1% | 1,420 | $5K | |
| 86140 | <1% | 4,337 | $5K | |
| 82607 | <1% | 597 | $4K | |
| 73502 | <1% | 420 | $4K | |
| 96368 | <1% | 468 | $4K | |
| 11721 | <1% | 316 | $4K | |
| 81003 | <1% | 12,217 | $4K | |
| 97112 | Therapeutic procedure, each 15 minutes; neuromuscular reeducation of movement, balance, coordination | <1% | 256 | $4K |
| 83615 | <1% | 4,238 | $4K | |
| 83540 | <1% | 1,458 | $4K | |
| 84112 | <1% | 664 | $4K | |
| 87086 | Culture, bacterial; quantitative colony count, urine | <1% | 4,826 | $4K |
| 88305 | Level IV - Surgical pathology, gross and microscopic examination | <1% | 4,826 | $4K |
| 83520 | <1% | 522 | $4K | |
| 86850 | <1% | 2,656 | $4K | |
| 84702 | <1% | 2,443 | $4K | |
| 97605 | <1% | 44 | $4K | |
| 84439 | <1% | 505 | $4K | |
| 78815 | Positron emission tomography (PET) for limited area imaging | <1% | 14 | $4K |
| 86900 | <1% | 3,944 | $4K | |
| 83498 | <1% | 491 | $3K | |
| 97124 | <1% | 237 | $3K | |
| 73560 | <1% | 165 | $3K | |
| 82017 | <1% | 488 | $3K | |
| 81025 | <1% | 10,121 | $3K | |
| 81001 | <1% | 13,007 | $3K | |
| J9190 | Injection, fluorouracil, 500 mg | <1% | 57 | $3K |
| 99205 | Prolong outpt/office vis | <1% | 27 | $3K |
| 85652 | <1% | 4,015 | $3K | |
| 20610 | <1% | 26 | $3K | |
| 85610 | <1% | 8,932 | $3K | |
| 84479 | <1% | 631 | $2K | |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | <1% | 994 | $2K |
| 82139 | <1% | 508 | $2K | |
| 82775 | <1% | 484 | $2K | |
| 82261 | <1% | 484 | $2K | |
| 92558 | <1% | 47 | $2K | |
| 80306 | <1% | 3,057 | $2K | |
| 77066 | Tomosynthesis, mammo | <1% | 98 | $2K |
| 90674 | <1% | 204 | $2K | |
| 82746 | <1% | 493 | $2K | |
| 82043 | <1% | 1,177 | $2K | |
| 86901 | <1% | 4,341 | $2K | |
| 86780 | <1% | 546 | $2K | |
| 83690 | <1% | 10,823 | $2K | |
| 71250 | <1% | 87 | $2K | |
| 87340 | <1% | 530 | $2K | |
| 87389 | Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies | <1% | 681 | $2K |
| 84030 | <1% | 484 | $2K | |
| 90461 | <1% | 819 | $2K | |
| 0072A | <1% | 43 | $2K | |
| 70551 | Magnetic resonance imaging, brain; without contrast material | <1% | 12 | $2K |
| Q0138 | Injection, ferumoxytol, for treatment of iron deficiency anemia, 1 mg (non-esrd use) | <1% | 20 | $2K |
| 84703 | <1% | 1,392 | $2K | |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | <1% | 8,816 | $2K |
| 90656 | <1% | 793 | $2K | |
| 73564 | <1% | 49 | $2K | |
| 85007 | <1% | 1,894 | $2K | |
| 96375 | Therapeutic injection; each additional sequential IV push | <1% | 11,268 | $2K |
| 86762 | <1% | 332 | $2K | |
| 90707 | <1% | 2,008 | $2K | |
| 92521 | <1% | 23 | $1K | |
| 73590 | <1% | 114 | $1K | |
| 90671 | <1% | 3,551 | $1K | |
| 84450 | <1% | 736 | $1K | |
| 82947 | <1% | 2,641 | $1K | |
| 77065 | Tomosynthesis, mammo | <1% | 60 | $1K |
| 93017 | <1% | 12 | $1K | |
| 92524 | <1% | 26 | $1K | |
| 97597 | <1% | 48 | $1K | |
| 86710 | <1% | 2,300 | $1K | |
| 84460 | <1% | 781 | $1K | |
| 69210 | <1% | 13 | $1K | |
| 93970 | <1% | 13 | $1K | |
| 73140 | <1% | 86 | $1K | |
| 82550 | <1% | 2,965 | $987.81 | |
| 85730 | <1% | 7,962 | $987.31 | |
| 82962 | <1% | 3,588 | $984.98 | |
| 86803 | <1% | 249 | $980.13 | |
| 76870 | <1% | 13 | $969.64 | |
| 0012A | <1% | 31 | $920.27 | |
| 0071A | <1% | 22 | $881.20 | |
| 81002 | <1% | 4,061 | $846.23 | |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | <1% | 7,955 | $832.86 |
| 70486 | <1% | 37 | $808.52 | |
| 90832 | Psychotherapy session, about 30 minutes | <1% | 483 | $792.62 |
| 82150 | <1% | 3,558 | $716.06 | |
| 99392 | Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) | <1% | 473 | $705.91 |
| 97014 | <1% | 83 | $684.06 | |
| 90756 | <1% | 80 | $658.31 | |
| 86003 | <1% | 99 | $651.25 | |
| 93010 | Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only | <1% | 124 | $634.89 |
| 82105 | <1% | 84 | $599.90 | |
| 92522 | <1% | 13 | $587.19 | |
| 99391 | Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) | <1% | 629 | $582.31 |
| 82248 | <1% | 192 | $568.20 | |
| 87637 | Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV | <1% | 1,063 | $555.11 |
| 74022 | <1% | 288 | $542.86 | |
| 90473 | <1% | 40 | $518.00 | |
| 84100 | <1% | 1,444 | $513.76 | |
| 92610 | <1% | 12 | $508.94 | |
| 83655 | <1% | 51 | $508.09 | |
| 97032 | <1% | 94 | $504.60 | |
| 84550 | <1% | 516 | $491.33 | |
| 99381 | <1% | 45 | $485.00 | |
| 90688 | <1% | 98 | $478.20 | |
| 85018 | <1% | 115 | $477.75 | |
| 0011A | <1% | 17 | $468.70 | |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 2,937 | $449.40 |
| 84153 | <1% | 83 | $432.16 | |
| 90660 | <1% | 57 | $403.95 | |
| 88304 | <1% | 348 | $395.55 | |
| 97535 | Self-care/home management training, each 15 minutes | <1% | 17 | $379.06 |
| 77002 | <1% | 17 | $368.93 | |
| 87661 | Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe | <1% | 54 | $351.02 |
| 80076 | <1% | 52 | $340.52 | |
| 86695 | <1% | 62 | $331.16 | |
| 96376 | <1% | 2,688 | $296.66 | |
| 90620 | <1% | 149 | $284.17 | |
| 86317 | <1% | 29 | $283.46 | |
| 90685 | <1% | 30 | $279.84 | |
| 90732 | <1% | 51 | $268.00 | |
| 73090 | <1% | 20 | $267.33 | |
| 88342 | <1% | 812 | $263.90 | |
| 84481 | <1% | 61 | $256.75 | |
| 87088 | <1% | 955 | $237.29 | |
| 86160 | <1% | 53 | $229.68 | |
| 86696 | <1% | 62 | $224.43 | |
| 87186 | <1% | 1,147 | $216.53 | |
| 90680 | <1% | 8,780 | $206.84 | |
| 87070 | <1% | 524 | $193.64 | |
| 90694 | <1% | 398 | $190.99 | |
| 87205 | <1% | 334 | $183.06 | |
| 87807 | <1% | 1,572 | $182.29 | |
| 94760 | <1% | 2,028 | $180.48 | |
| 72072 | <1% | 13 | $171.90 | |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | <1% | 6,985 | $163.31 |
| 82785 | <1% | 16 | $160.54 | |
| 90632 | <1% | 35 | $148.82 | |
| 94664 | <1% | 435 | $148.53 | |
| 83516 | <1% | 37 | $139.70 | |
| 83001 | <1% | 26 | $123.64 | |
| G0008 | Administration of influenza virus vaccine | <1% | 1,112 | $121.89 |
| 80074 | <1% | 16 | $119.75 | |
| 73080 | <1% | 14 | $118.17 | |
| 86480 | <1% | 15 | $117.70 | |
| 87430 | <1% | 619 | $112.98 | |
| 86704 | <1% | 17 | $112.78 | |
| 76000 | <1% | 106 | $98.67 | |
| 86255 | <1% | 13 | $93.86 | |
| 90723 | <1% | 2,052 | $87.75 | |
| 84156 | <1% | 45 | $87.25 | |
| 82378 | <1% | 41 | $85.41 | |
| 90698 | <1% | 4,855 | $83.80 | |
| 87081 | <1% | 579 | $82.82 | |
| 86038 | <1% | 14 | $78.96 | |
| 36416 | <1% | 219 | $78.82 | |
| 73600 | <1% | 17 | $75.56 | |
| U0005 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 | <1% | 3,029 | $75.00 |
| 80050 | General health panel | <1% | 30 | $64.57 |
| 99000 | <1% | 176 | $62.00 | |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | <1% | 7,166 | $58.51 |
| 87077 | <1% | 447 | $58.46 | |
| J7120 | Ringers lactate infusion, up to 1000 cc | <1% | 2,581 | $54.75 |
| 84403 | <1% | 12 | $49.73 | |
| 86769 | <1% | 34 | $48.38 | |
| J2704 | Injection, propofol, 10 mg | <1% | 7,935 | $47.97 |
| 74019 | <1% | 13 | $42.38 | |
| 82784 | <1% | 12 | $40.72 | |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | <1% | 4,574 | $40.46 |
| 90672 | <1% | 165 | $39.79 | |
| G0009 | Administration of pneumococcal vaccine | <1% | 88 | $37.41 |
| 88312 | <1% | 142 | $35.86 | |
| 86765 | <1% | 13 | $33.61 | |
| 90710 | <1% | 4,667 | $33.52 | |
| 90474 | <1% | 1,046 | $30.00 | |
| 85008 | <1% | 1,630 | $29.37 | |
| J7030 | Infusion, normal saline solution , 1000 cc | <1% | 7,055 | $29.24 |
| 86920 | <1% | 59 | $27.81 | |
| 82565 | <1% | 84 | $27.61 | |
| 82010 | <1% | 88 | $27.25 | |
| 82272 | <1% | 43 | $23.12 | |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | <1% | 333 | $22.81 |
| 82948 | <1% | 79 | $20.42 | |
| J2710 | Injection, neostigmine methylsulfate, up to 0.5 mg | <1% | 640 | $18.06 |
| J2270 | Injection, morphine sulfate, up to 10 mg | <1% | 772 | $14.50 |
| 88313 | <1% | 62 | $13.84 | |
| J2930 | Injection, methylprednisolone sodium succinate, up to 125 mg | <1% | 626 | $12.71 |
| 91301 | <1% | 70 | $11.76 | |
| J1170 | Injection, hydromorphone, up to 4 mg | <1% | 4,157 | $10.91 |
| Q0162 | Ondansetron 1 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen | <1% | 819 | $10.84 |
| A9585 | Injection, gadobutrol, 0.1 ml | <1% | 151 | $7.51 |
| J3010 | Injection, fentanyl citrate, 0.1 mg | <1% | 3,256 | $6.33 |
| J2550 | Injection, promethazine hcl, up to 50 mg | <1% | 1,244 | $6.24 |
| J0690 | Injection, cefazolin sodium, 500 mg | <1% | 1,251 | $4.20 |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | <1% | 1,371 | $4.16 |
| 82800 | <1% | 55 | $3.70 | |
| J7040 | Infusion, normal saline solution, sterile (500 ml = 1 unit) | <1% | 1,140 | $1.36 |
| J1644 | Injection, heparin sodium, per 1000 units | <1% | 577 | $1.03 |
| 82805 | <1% | 65 | $0.96 | |
| J2060 | Injection, lorazepam, 2 mg | <1% | 1,407 | $0.78 |
| J7050 | Infusion, normal saline solution, 250 cc | <1% | 3,198 | $0.64 |
| 36600 | <1% | 65 | $0.12 | |
| J7613 | Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg | <1% | 626 | $0.12 |
| 90700 | 0% | 2,871 | $0.00 | |
| 90633 | 0% | 6,809 | $0.00 | |
| A4216 | Sterile water, saline and/or dextrose, diluent/flush, 10 ml | 0% | 611 | $0.00 |
| 90621 | 0% | 14 | $0.00 | |
| J1650 | Injection, enoxaparin sodium, 10 mg | 0% | 556 | $0.00 |
| C1776 | Joint device (implantable) | 0% | 415 | $0.00 |
| C1713 | Anchor/screw for opposing bone-to-bone or soft tissue-to-bone (implantable) | 0% | 386 | $0.00 |
| J1200 | Injection, diphenhydramine hcl, up to 50 mg | 0% | 952 | $0.00 |
| 90380 | 0% | 32 | $0.00 | |
| A9577 | Injection, gadobenate dimeglumine (multihance), per ml | 0% | 495 | $0.00 |
| J0640 | Injection, leucovorin calcium, per 50 mg | 0% | 57 | $0.00 |
| 99394 | Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) | 0% | 47 | $0.00 |
| 99173 | 0% | 16 | $0.00 | |
| 90649 | 0% | 100 | $0.00 | |
| 96417 | 0% | 68 | $0.00 | |
| 99393 | Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) | 0% | 235 | $0.00 |
| S0164 | Injection, pantoprazole sodium, 40 mg | 0% | 45 | $0.00 |
| S0028 | Injection, famotidine, 20 mg | 0% | 190 | $0.00 |
| A4315 | Insertion tray with drainage bag with indwelling catheter, foley type, two-way, all silicone | 0% | 25 | $0.00 |
| C9113 | Injection, pantoprazole sodium, per vial | 0% | 124 | $0.00 |
| J3475 | Injection, magnesium sulfate, per 500 mg | 0% | 599 | $0.00 |
| J0694 | Injection, cefoxitin sodium, 1 gm | 0% | 118 | $0.00 |
| 90653 | 0% | 61 | $0.00 | |
| 77062 | 0% | 13 | $0.00 | |
| 51702 | 0% | 43 | $0.00 | |
| 98926 | 0% | 13 | $0.00 | |
| 0502F | 0% | 661 | $0.00 | |
| 94690 | 0% | 28 | $0.00 | |
| Q9966 | Low osmolar contrast material, 200-299 mg/ml iodine concentration, per ml | 0% | 19 | $0.00 |
| 90662 | 0% | 97 | $0.00 | |
| J0171 | Injection, adrenalin, epinephrine, 0.1 mg | 0% | 52 | $0.00 |
| A9552 | Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries | 0% | 15 | $0.00 |
| J2001 | Injection, lidocaine hcl for intravenous infusion, 10 mg | 0% | 626 | $0.00 |
| J2250 | Injection, midazolam hydrochloride, per 1 mg | 0% | 1,451 | $0.00 |
| 90744 | 0% | 1,436 | $0.00 | |
| 90696 | 0% | 3,143 | $0.00 | |
| 90716 | 0% | 2,114 | $0.00 | |
| J1642 | Injection, heparin sodium, (heparin lock flush), per 10 units | 0% | 7,088 | $0.00 |
| 90697 | 0% | 3,926 | $0.00 | |
| J2543 | Injection, piperacillin sodium/tazobactam sodium, 1 gram/0.125 grams (1.125 grams) | 0% | 291 | $0.00 |
| J0330 | Injection, succinylcholine chloride, up to 20 mg | 0% | 240 | $0.00 |
| 99024 | 0% | 247 | $0.00 | |
| 99406 | 0% | 126 | $0.00 | |
| 82803 | 0% | 54 | $0.00 | |
| 90619 | 0% | 1,181 | $0.00 | |
| J3410 | Injection, hydroxyzine hcl, up to 25 mg | 0% | 99 | $0.00 |
| J7620 | Albuterol, up to 2.5 mg and ipratropium bromide, up to 0.5 mg, fda-approved final product, non-compounded, administered through dme | 0% | 138 | $0.00 |
| J7060 | 5% dextrose/water (500 ml = 1 unit) | 0% | 511 | $0.00 |
| J1030 | Injection, methylprednisolone acetate, 40 mg | 0% | 61 | $0.00 |
| 80329 | 0% | 743 | $0.00 | |
| J3480 | Injection, potassium chloride, per 2 meq | 0% | 110 | $0.00 |
| 51798 | 0% | 78 | $0.00 | |
| J3360 | Injection, diazepam, up to 5 mg | 0% | 45 | $0.00 |
| J7512 | Prednisone, immediate release or delayed release, oral, 1 mg | 0% | 185 | $0.00 |
| 90381 | 0% | 29 | $0.00 | |
| J2370 | Injection, phenylephrine hcl, up to 1 ml | 0% | 31 | $0.00 |
| J1815 | Injection, insulin, per 5 units | 0% | 69 | $0.00 |
| 82330 | 0% | 15 | $0.00 | |
| C1769 | Guide wire | 0% | 48 | $0.00 |
| J2765 | Injection, metoclopramide hcl, up to 10 mg | 0% | 87 | $0.00 |
| J3420 | Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg | 0% | 36 | $0.00 |
| J1940 | Injection, furosemide, up to 20 mg | 0% | 15 | $0.00 |
| C1781 | Mesh (implantable) | 0% | 13 | $0.00 |
| J0561 | Injection, penicillin g benzathine, 100,000 units | 0% | 14 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialLAWRENCE, CHARLOTTE (SECRETARY)
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.